Bluebird bio Inc (NASDAQ: BLUE) on Monday, plunged -1.25% from the previous trading day, before settling in for the closing price of $1.00. Within the past 52 weeks, BLUE’s price has moved between $0.85 and $5.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 120.04% over the last five years. The company achieved an average annual earnings per share of 10.93%. With a float of $189.84 million, this company’s outstanding shares have now reached $192.74 million.
Bluebird bio Inc (BLUE) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Bluebird bio Inc is 1.51%, while institutional ownership is 53.75%. The most recent insider transaction that took place on Jun 03 ’24, was worth 3,726. In this transaction an insider of this company sold 3,834 shares at a rate of $0.97, taking the stock ownership to the 121,006 shares. Before that another transaction happened on Mar 04 ’24, when Company’s President and CEO sold 6,095 for $1.53, making the entire transaction worth $9,311. This insider now owns 279,998 shares in total.
Bluebird bio Inc (BLUE) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 10.93% per share during the next fiscal year.
Bluebird bio Inc (NASDAQ: BLUE) Trading Performance Indicators
Bluebird bio Inc (BLUE) is currently performing well based on its current performance indicators. A quick ratio of 1.42 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.74, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.17 in one year’s time.
Technical Analysis of Bluebird bio Inc (BLUE)
Analysing the last 5-days average volume posted by the [Bluebird bio Inc, BLUE], we can find that recorded value of 4.73 million was lower than the volume posted last year of 7.39 million. As of the previous 9 days, the stock’s Stochastic %D was 23.45%. Additionally, its Average True Range was 0.10.
During the past 100 days, Bluebird bio Inc’s (BLUE) raw stochastic average was set at 21.47%, which indicates a significant increase from 18.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.91% in the past 14 days, which was higher than the 84.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.0328, while its 200-day Moving Average is $1.5839. Now, the first resistance to watch is $1.0151. This is followed by the second major resistance level at $1.0466. The third major resistance level sits at $1.0733. If the price goes on to break the first support level at $0.9569, it is likely to go to the next support level at $0.9302. Should the price break the second support level, the third support level stands at $0.8987.
Bluebird bio Inc (NASDAQ: BLUE) Key Stats
Market capitalization of the company is 189.56 million based on 109,336K outstanding shares. Right now, sales total 3,600 K and income totals -266,580 K. The company made 12,390 K in profit during its latest quarter, and -71,730 K in sales during its previous quarter.
